For more than 25 years, Oppenheimer has been proud to partner with one of the world’s most innovative leaders in biosolutions — Novonesis, formerly known as Novozymes.
In 2024, Novozymes and Chr. Hansen came together to form Novonesis, creating a global powerhouse in industrial enzymes and microbial solutions. Today, Novonesis is leading the way in transforming how the world produces and consumes almost everything through the power of biology.
With a strong focus on sustainability, efficiency, and innovation, Novonesis develops biosolutions that help industries improve yields, reduce waste, save energy, and create smarter, more sustainable products. Their technologies support a wide range of sectors, including food and beverages, household care, agriculture, pharmaceuticals, and bioenergy.
At Oppenheimer, we are incredibly proud to have shared such a long and successful partnership with Novonesis. Over the past two and a half decades, we have witnessed firsthand their commitment to scientific excellence, innovation, and creating positive change through biology.
As Novonesis continues to shape the future of biosolutions globally, we look forward to continuing our strong partnership and supporting the shared vision of building a better and, more sustainable world through science and innovation.
Congratulations to the entire Novonesis team on this exciting journey and remarkable achievement.
